SEATTLE, July 30, 2021, (MEDGADGET) — Global Cardiac Rhythm Management Devices Batteries Market Analysis

Overview

Biomedical instruments that can be implanted. In cardiac rhythm management (CRM) applications, batteries are used. In the treatment of coronary diseases, CRM instruments are used (CVDs). Implantable cardiac pacemakers (ICP), implantable cardioverter defibrillators (ICD), and cardiac resynchronization therapy systems are examples of implantable cardiac devices (CRT).

Statistics

The demand for the global cardiac rhythm management devices batteries market is forecast to be worth US$ 446.1 million in 2019 and US$ 581.0 million by 2027.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/3173

Drivers

Over the forecast period, the global cardiac rhythm management devices batteries market is expected to rise due to rising acceptance and innovation in lithium anode batteries. This is due to lithium anode batteries’ several benefits, including their lightweight, high stability and predictability, high energy capacity, compact scale, and high durability.

R&D in lithium anode batteries is a priority for major institutes. In July 2018, a study published in the journal MDPI Membranes titled ‘Ionic Liquid-Based Electrolyte Membranes for Medium-High Temperature Lithium Polymer Batteries’ announced the synthesis of PEO-LiTFSI Li+-conducting membranes containing the PYR14TFSI ionic liquid as electrolyte separators for all-solid-state lithium polymer batteries operating at medium-high temperatures.’ In comparison to ionic liquid-free electrolytes, the novel device demonstrated better thermal, ion transfer, and interfacial properties.

Furthermore, advancements in CRM products are projected to drive demand growth of the global cardiac rhythm management devices batteries market over the forecast period. Research published in the journal Biomaterials in October 2019 called “Micro engineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices” described the creation of a cellulose-based protective membrane that reduces the build-up of fibrotic tissue around cardiac pacemaker implants.

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3173

Statistics

In terms of size, North America dominated the global heart rhythm management devices batteries market in 2018, contributing to 37.7 percent of the overall market share, led by Europe.

Restraints

The global cardiac rhythm management devices batteries market is expected to be hampered by an increase in product recalls associated with CRM devices. Medtronic, Inc. recalled 13,440 dual-chamber implantable pulse generators in the United States in February 2019 due to the risk of a technical error causing the machines to lose pacing ability.

Since Li-Ion batteries will explode if they are overcharged or discharged too far, they must be protected. Over the forecast period, such disadvantages are likely to stifle the growth of the global cardiac rhythm management devices batteries market.

Opportunities

The market’s major players will concentrate on sodium-ion battery research and development. While lithium-ion batteries are a popular form of energy storage, depleting lithium supplies and the high costs associated with mining and refining could open the door for other options. Sodium-ion batteries are less expensive and have a reliable service. As a result, market participants should predict profitable growth prospects as sodium-ion batteries become more widely used in CRM applications.

Furthermore, due to the rising prevalence of CVDs and other heart-related diseases in the population, demand for CRM devices is expected to rise, boosting the global cardiac rhythm management devices batteries market. As per the 2018 Heart Disease and Stroke Statistics published by the American Heart Association, at its peak, CVDs were responsible for almost 836,546 deaths in the U.S. Furthermore, approximately 2,300 deaths are recorded in the U.S. per day as a result of CVDs, averaging one death every 38 seconds.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/cardiac-rhythm-management-devices-batteries-market-2575

The product class segment of the global cardiac rhythm management devices batteries market was worth US$ 431.6 million in 2018 and is projected to grow at a CAGR of 3.4 percent to US$ 581.0 million by 2027.

Market Trends

The cost of lithium batteries has decreased as lithium demand has increased. Furthermore, lithium battery producers are concentrating their efforts on land acquisition and exploration in order to boost lithium demand.

Cathode materials can increase the risk of serious problems, prompting manufacturers to shift their attention to less toxic battery chemistry. Silver vanadium oxide is becoming more common as a cathode material for CRM devices. Over the forecast period, such scenarios are expected to help in the development of the global cardiac rhythm management devices batteries market.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3173

Competitive Landscape

Key companies contributing to the global cardiac rhythm management devices batteries market are Greatbatch, Inc., Boston Scientific Corporation, Medtronic, Inc., BIOTRONIK SE & Co. KG., Quallion LLC, St. Jude Medical, Inc., and EaglePicher Technologies, LLC.

Key Developments

The market’s growth is likely to be hampered by an increase in product recalls and warnings. In May 2019, the US Food and Drug Administration (FDA) issued an alert about premature battery degradation in Medtronic, Inc.’s Azure, Astra, Percepta, Serena, and Solara pacemaker models.

The FDA sent a warning to Zeller Power Products, a battery manufacturer for Cardiac Science’s PowerHeart Automated External Defibrillator (AED) G3, in November 2018 due to the lack of design validation documents to support the battery’s five-year shelf life.

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By Power Source
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Technological Advancement
   • Regulatory Scenario
4. Global Cardiac Rhythm Management Device Batteries Market, By Product Type, 2017 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2019–2027
     • Segment Trends
   • Implantable Cardiac Pacemaker
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
     • Segment Trends
   • Implantable Cardioverter Defibrillator
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
     • Segment Trends
   • Cardiac Resynchronization Device
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
     • Segment Trends
5. Global Cardiac Rhythm Management Device Batteries Market, By Power Source, 2017 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2019–2027
     • Segment Trends
   • Lithium-Iodine Cells
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
   • Lithium-Silver Vanadium Oxide Cell
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
   • Lithium-Carbon Monofluride Cells
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
   • Lithium-Manganese Dioxide
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
6. Competitive Landscape
   • Heat Map Analysis
   • Company Profiles
7. Section
   • References
   • Research Methodology
   • About us and Sales Contact

Have a Look at Related Research Insights:

Enteral Feeding Devices Market To Surpass US$ 4,853.8 Million By 2027

U.K. Drug For Abuse Testing Devices Market To Surpass US$ 389.1 Million By 2027

Transient Elastography Devices Market To Surpass US$ 106.1 Million By 2028

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837